• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有胆管癌栓的肝细胞癌的手术治疗结果:一项系统评价

Surgical outcomes of hepatocellular carcinoma with biliary tumor thrombus: a systematic review.

作者信息

Qiao Wenhui, Yu Feng, Wu Lupeng, Li Bin, Zhou Yanming

机构信息

Department of General Surgery, First Hospital of Lanzhou University, Lanzhou, China.

Department of Hepatobiliary Surgery, No.101 Hospital of CPLA, Wuxi, China.

出版信息

BMC Gastroenterol. 2016 Jan 28;16:11. doi: 10.1186/s12876-016-0427-2.

DOI:10.1186/s12876-016-0427-2
PMID:26822229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4730620/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) with biliary tumor thrombus (BTT) is rare and its impact on postoperative prognosis remains controversial. The aim of this study was to evaluate the published evidence concerning the outcome of surgical resection of HCC with BTT.

METHODS

Eligible studies were identified by searching PubMed and reviewed systematically. Comparisons of the clinicopathologic features and surgical outcomes for HCC patients with or without BTT were analyzed using meta-analytical techniques.

RESULTS

Twenty retrospective studies containing 598 patients that met the selection criteria were included for review. The perioperative mortality was 2.1 % (range, 0-10 %), and the median 5-year overall survival (OS) was 24 % (range, 0-48 %) with a recurrence rate of 63.9 % (range, 42-91 %). Pooled analysis of 13 comparative studies showed that HCC patients with BTT had a higher incidence of vascular invasion (odds ratio [OR]: 4.70, 95 % CI: 2.90-7.60; P <0.001), a higher frequency of poor differentiation (OR: 2.07, 95 % CI: 1.23-3.49; P = 0.006), and a shorter 5-year OS rate (OR: 0.31, 95 % CI: 0.21-0.64; P <0.001) than those without BTT.

CONCLUSIONS

Although HCC with BTT has more aggressive biological characteristics and is an indicator of poor prognosis, surgical resection can still provide long-term survival for some patients.

摘要

背景

伴有胆管肿瘤血栓(BTT)的肝细胞癌(HCC)较为罕见,其对术后预后的影响仍存在争议。本研究旨在评估已发表的关于伴有BTT的HCC手术切除结果的证据。

方法

通过检索PubMed确定符合条件的研究并进行系统综述。采用荟萃分析技术分析有或无BTT的HCC患者的临床病理特征和手术结果的比较。

结果

纳入20项回顾性研究,共598例符合选择标准的患者进行综述。围手术期死亡率为2.1%(范围0 - 10%),5年总生存率(OS)中位数为24%(范围0 - 48%),复发率为63.9%(范围42 - 91%)。13项比较研究的汇总分析显示,伴有BTT的HCC患者血管侵犯发生率更高(比值比[OR]:4.70,95%置信区间[CI]:2.90 - 7.60;P < 0.001),低分化频率更高(OR:2.07,95% CI:1.23 - 3.49;P = 0.006),5年OS率低于无BTT的患者(OR:0.31,95% CI:0.21 - 0.64;P < 0.001)。

结论

尽管伴有BTT的HCC具有更具侵袭性的生物学特征且是预后不良的指标,但手术切除仍可为部分患者提供长期生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/4730620/f063ce13e4c1/12876_2016_427_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/4730620/7784750d83f4/12876_2016_427_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/4730620/5fd5db5e015d/12876_2016_427_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/4730620/c01dcafbd506/12876_2016_427_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/4730620/f063ce13e4c1/12876_2016_427_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/4730620/7784750d83f4/12876_2016_427_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/4730620/5fd5db5e015d/12876_2016_427_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/4730620/c01dcafbd506/12876_2016_427_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee2e/4730620/f063ce13e4c1/12876_2016_427_Fig4_HTML.jpg

相似文献

1
Surgical outcomes of hepatocellular carcinoma with biliary tumor thrombus: a systematic review.伴有胆管癌栓的肝细胞癌的手术治疗结果:一项系统评价
BMC Gastroenterol. 2016 Jan 28;16:11. doi: 10.1186/s12876-016-0427-2.
2
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
3
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.早期或极早期肝细胞癌患者的管理:一项网络荟萃分析尝试
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2.
4
Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study.利用术前甲胎蛋白和异常凝血酶原水平对肝细胞癌预后进行聚类分析:一项多机构研究
J Gastrointest Surg. 2025 Apr;29(4):101980. doi: 10.1016/j.gassur.2025.101980. Epub 2025 Jan 28.
5
Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma.系统评价:肝移植治疗肝细胞癌后甲胎蛋白的预后作用。
Aliment Pharmacol Ther. 2012 May;35(9):987-99. doi: 10.1111/j.1365-2036.2012.05060.x. Epub 2012 Mar 20.
6
[Comparison of the efficacy of anatomical resection versus hepatic parenchymal preservation preference in patients with solitary small hepatocellular carcinoma and cirrhosis: a multicenter retrospective study].[孤立性小肝细胞癌合并肝硬化患者解剖性切除与肝实质保留优先策略疗效比较:一项多中心回顾性研究]
Zhonghua Gan Zang Bing Za Zhi. 2025 Apr 20;33(4):348-358. doi: 10.3760/cma.j.cn501113-20250315-00097.
7
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
10
Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus.肝细胞癌(HCC)伴或不伴胆管血栓患者肝切除术后结局的系统评价和荟萃分析
HPB (Oxford). 2016 Apr;18(4):312-6. doi: 10.1016/j.hpb.2015.12.003. Epub 2016 Feb 18.

引用本文的文献

1
Radiomics analysis of R2* maps to predict early recurrence of single hepatocellular carcinoma after hepatectomy.基于R2*图的影像组学分析预测肝细胞癌肝切除术后早期复发
Front Oncol. 2024 Feb 23;14:1277698. doi: 10.3389/fonc.2024.1277698. eCollection 2024.
2
Phase Attention Model for Prediction of Early Recurrence of Hepatocellular Carcinoma With Multi-Phase CT Images and Clinical Data.基于多期CT图像和临床数据预测肝细胞癌早期复发的相位注意力模型
Front Radiol. 2022 Mar 24;2:856460. doi: 10.3389/fradi.2022.856460. eCollection 2022.
3
Imaging Features of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Multicenter Study.

本文引用的文献

1
Bile duct preserving surgery for hepatocellular carcinoma with bile duct tumor thrombus.保留胆管的肝细胞癌合并胆管癌栓手术
Ann Surg. 2015 May;261(5):e123-5. doi: 10.1097/SLA.0000000000001209.
2
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.细胞因子诱导的杀伤细胞过继免疫治疗肝癌。
Gastroenterology. 2015 Jun;148(7):1383-91.e6. doi: 10.1053/j.gastro.2015.02.055. Epub 2015 Mar 4.
3
Incidental microscopic bile duct tumor thrombi in hepatocellular carcinoma after curative hepatectomy: a matched study.
伴胆管癌栓的肝细胞癌的影像学特征:一项多中心研究
Front Oncol. 2021 Nov 5;11:723455. doi: 10.3389/fonc.2021.723455. eCollection 2021.
4
A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma.基于联合全身和肝脏炎症标志物的列线图预测肝细胞癌中的微小胆管癌栓。
BMC Cancer. 2021 Mar 12;21(1):272. doi: 10.1186/s12885-021-07956-9.
5
Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study.术后辅助经动脉化疗栓塞改善伴胆管癌栓肝细胞癌的短期预后:一项倾向评分匹配研究
Cancer Manag Res. 2020 Sep 28;12:9183-9195. doi: 10.2147/CMAR.S270467. eCollection 2020.
6
SNPs predict better prognosis in HBV-related hepatocellular carcinoma patients.单核苷酸多态性可预测乙肝相关肝细胞癌患者的预后更佳。
Int J Clin Exp Pathol. 2018 Jun 1;11(6):3165-3175. eCollection 2018.
7
Glycogen synthase kinase-3β inhibition promotes lysosome-dependent degradation of c-FLIP in hepatocellular carcinoma.糖原合酶激酶-3β抑制促进肝癌细胞中 c-FLIP 的溶酶体依赖性降解。
Cell Death Dis. 2018 Feb 14;9(2):230. doi: 10.1038/s41419-018-0309-3.
8
Clinical role and biological function of CDK5 in hepatocellular carcinoma: A study based on immunohistochemistry, RNA-seq and investigation.CDK5在肝细胞癌中的临床作用及生物学功能:一项基于免疫组织化学、RNA测序和研究的分析。 (你原文中“investigation”前面应该还有内容,这里翻译的句子不太完整,推测是这样的意思,你可以补充完整内容以便更准确翻译。)
Oncotarget. 2017 Nov 26;8(65):108333-108354. doi: 10.18632/oncotarget.22659. eCollection 2017 Dec 12.
9
Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma.整合素变体及表达在乙型肝炎病毒相关肝细胞癌术后患者中的预后价值
Oncotarget. 2017 Aug 10;8(44):76816-76831. doi: 10.18632/oncotarget.20161. eCollection 2017 Sep 29.
10
A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus.一项关于19例伴有胆管癌栓的肝细胞癌患者的单机构报告。
J Hepatocell Carcinoma. 2017 Mar 7;4:41-47. doi: 10.2147/JHC.S126308. eCollection 2017.
根治性肝切除术后肝细胞癌中偶然发现的微小胆管肿瘤血栓:一项配对研究
Medicine (Baltimore). 2015 Feb;94(6):e450. doi: 10.1097/MD.0000000000000450.
4
Hepatocellular carcinoma with bile duct tumor thrombus: surgical outcomes and the prognostic impact of concomitant major vascular invasion.伴有胆管瘤栓的肝细胞癌:手术结果及伴发主要血管侵犯的预后影响
World J Surg. 2015 Jun;39(6):1485-93. doi: 10.1007/s00268-015-2985-9.
5
Bile duct thrombi in hepatocellular carcinoma: is aggressive surgery worthwhile?肝细胞癌中的胆管血栓形成:积极手术是否值得?
HPB (Oxford). 2015 Jun;17(6):508-13. doi: 10.1111/hpb.12383. Epub 2015 Jan 9.
6
Hepatocellular carcinoma with bile duct tumor thrombus: a clinicopathological analysis of factors predictive of recurrence and outcome after surgery.伴有胆管瘤栓的肝细胞癌:术后复发及预后预测因素的临床病理分析
Medicine (Baltimore). 2015 Jan;94(1):e364. doi: 10.1097/MD.0000000000000364.
7
Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus.肝细胞癌合并胆管癌栓行肝切除的疗效
HPB (Oxford). 2015 May;17(5):401-8. doi: 10.1111/hpb.12368. Epub 2014 Nov 19.
8
Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus.肝癌合并大的胆管癌栓切除的价值。
Anticancer Res. 2014 Aug;34(8):4367-72.
9
Antiviral therapy decreases recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection: a meta-analysis.抗病毒治疗可降低根治性切除术后乙型肝炎病毒相关肝细胞癌的复发率:一项荟萃分析。
World J Surg. 2014 Sep;38(9):2395-402. doi: 10.1007/s00268-014-2586-z.
10
Long-term survival analysis of liver transplantation for hepatocellular carcinoma with bile duct tumor thrombus.伴有胆管癌栓的肝细胞癌肝移植长期生存分析
Transplant Proc. 2014 Apr;46(3):774-7. doi: 10.1016/j.transproceed.2013.10.053.